GlassScriptPhysician profile
Matthew L Bilodeau
NPI 1457408320
$2,778.23
in general payments reported to CMS, 2019-2025
16 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $129 · 2021: $165 · 2022: $540 · 2023: $586 · 2024: $875 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,833.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $1,168.79 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $345.18 | 2021-2025 | Cardiomems, Xience Skypoint |
| Medtronic, INC. | $301.95 | 2021-2024 | Ffrangio |
| Boston Scientific Corporation | $214.38 | 2019-2021 | |
| Cardiovascular Systems INC. | $165.27 | 2022 | |
| Edwards Lifesciences Corporation | $142.35 | 2024 | Sapien 3 Ultra Resilia |
| Biotronik INC. | $128.30 | 2023 | Orsiro Mission, Pantera Leo, Recross |
| Angiodynamics, INC. | $113.89 | 2023 | Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $67.21 | 2024 | |
| Penumbra, INC. | $39.54 | 2024 | Penumbra System |
| Canon Medical Systems USA, INC. | $27.37 | 2019 | |
| Philips North America LLC | $19.24 | 2022 | |
| Heartflow, INC. | $16.77 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $14.66 | 2023 | Inpefa |
| Medtronic Vascular, INC. | $13.33 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bilodeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.